Page last updated: 2024-10-29

avapro and Epilepsy

avapro has been researched along with Epilepsy in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Epilepsy: A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pinessi, L1
Ferrero, M1
Gentile, S1
Rainero, I1

Other Studies

1 other study available for avapro and Epilepsy

ArticleYear
Conversion from migraine without aura to typical aura without headache after irbesartan.
    The journal of headache and pain, 2005, Volume: 6, Issue:2

    Topics: Antihypertensive Agents; Biphenyl Compounds; Brain; Epilepsy; Female; Humans; Irbesartan; Middle Age

2005